PMI05

Precision Molecular

Drug Candidate

PMI05

Summary

Potential first-in-class imaging agent for CAIX associated cancers

Mechanism of Action

PET/SPECT ligand targeting CAIX

Indication

Oncology

Development Stage

Phase I